Anitha Vijayan, MD
Nephrology · Murray, UTNPI 1194741405
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.6%), speaking fees and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Fresenius USA Marketing, Inc. at 28.6% of the total. Reporting peaked in 2024 at $29,601 and has fallen 81.2% since, to $5,561 in 2025. Among nephrology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 138 payments — averaging $854.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius USA Marketing, Inc.$34K
- Nxstage Medical, Inc.$33K
- Sanofi$20K
- Baxter Healthcare$19K
- Astute Medical, Inc.$6K
- Calliditas Therapeutics US Inc.$2K
- plus $3K from 5 others
Across 14 payments — averaging $21,007 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Fresenius USA Marketing, Inc.$155K
- Fresenius Medical Care Renal Therapies Group, LLC.$139K
What the payments were for
- Consulting fees$47,91441%
- Speaking & faculty fees$37,32632%
- Travel & lodging$13,07711%
- Food & beverage$5,3505%
- Education$14,32112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fresenius USA Marketing, Inc. | 40 | $33,703 |
| Nxstage Medical, Inc. | 40 | $33,487 |
| Sanofi | 17 | $20,362 |
| Baxter Healthcare | 26 | $19,385 |
| Astute Medical, Inc. | 6 | $5,542 |
| Calliditas Therapeutics US Inc. | 4 | $2,327 |
| Quanta Dialysis Technologies Inc | 1 | $2,000 |
| Amgen | 1 | $900 |
| AstraZeneca | 1 | $150 |
| Mallinckrodt Enterprises LLC | 1 | $100 |
| Travere Therapeutics, Inc. | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NXSTAGE SYSTEM ONE$27,110
- ELITEK$20,156
- System One$16,289
- Renal - Acute$14,906
- TARPEYO$2,255
- NEPHROCHECK Liquid Control Kit$1,125
- NEPHROCHECK TEST$792
- Renal - CRRT$345
- SOLIRIS$150
- NOVALUNG SYSTEM$144
How this compares
$117,987 in reported general payments places this provider in the 95th percentile of 74 nephrology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorthalidone | 16 | $130 |
| Amlodipine Besylate | 19 | $65 |
| Pantoprazole Sodium | 14 | $61 |
| Allopurinol | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Murray
- Vishnu ParvathareddyMurray$4K
- Bogdan AneaMurray$2K
- Mark KrausMurray$1K
- Richard ClineMurray$780
- Sanjiv AnandSouth Salt Lake$144K
- Alfred CheungSalt Lake City$132K
- Donald KohanSalt Lake City$119K
- Fuad ShihabSalt Lake City$83K
- William BaragerProvo$13K
- Srinivasa BeddhuSalt Lake City$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.